Inventor

GREENE HOWARD E

US11 patents

⚠️ This page may combine multiple inventors who share the name “GREENE HOWARD E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SATIOGEN PHARMACEUTICALS INC

5 patents

US9345715B2May 24, 2016

Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereof

SATIOGEN PHARMACEUTICALS INC10 citations83

US11260053B2Mar 1, 2022

Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions

SATIOGEN PHARMACEUTICALS INC1 citations72

US10555950B2Feb 11, 2020

Bile acid recycling inhibitors for treatment of obesity and diabetes

SATIOGEN PHARMACEUTICALS INC2 citations72

US10251880B2Apr 9, 2019

Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions

SATIOGEN PHARMACEUTICALS INC3 citations72

US10028952B2Jul 24, 2018

Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereof

SATIOGEN PHARMACEUTICALS INC0 citations51

HYBRITECH INC

2 patents

US4486530ADec 4, 1984

Immunometric assays using monoclonal antibodies

HYBRITECH INC557 citations98

US4376110AMar 8, 1983

Immunometric assays using monoclonal antibodies

HYBRITECH INC2,743 citations98

YOUNG ANDREW A

2 patents

US9339480B2May 17, 2016

Bile acid recycling inhibitors for treatment of obesity and diabetes

YOUNG ANDREW A38 citations93

US8318663B2Nov 27, 2012

Methods of treating diabetes and/or obesity using an enteroendocrine peptide secretion enhancing agent

YOUNG ANDREW A9 citations83

GREENE HOWARD E

1 patent

US9656017B2May 23, 2017

Infusion delivery devices and methods

GREENE HOWARD E31 citations90

GEDULIN BRONISLAVA

1 patent

US10188646B2Jan 29, 2019

Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions

GEDULIN BRONISLAVA3 citations69